Micronutrient Deficiencies Seen in More Than 45 Percent With Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 30, 2025 -- More than 45 percent of patients with type 2 diabetes (T2D) have micronutrient deficiencies, with the most prevalent deficiency being vitamin D, according to a meta-analysis published online Jan. 28 in BMJ Nutrition Prevention & Health.
Daya Krishan Mangal, Ph.D., from the Indian Institute of Health Management Research in Jaipur, and colleagues conducted a comprehensive assessment of the burden of multiple micronutrient deficiencies among patients with T2D. A total of 132 studies with 52,501 participants were included in the analysis.
The researchers found that the pooled prevalence of multiple micronutrient deficiencies was 45.30 percent among patients with T2D. The pooled prevalence was higher in women with T2D (48.62 percent) than in men (42.53 percent). The most prevalent micronutrient deficiency was vitamin D followed by magnesium (60.45 and 41.95 percent, respectively). The metformin-consuming group had higher B12 deficiency (28.72 percent). Across World Health Organization regions, there was variation seen in the prevalence of micronutrient deficiency.
"Micronutrient deficiencies may influence glucose metabolism and insulin signaling pathways, leading to the onset and progression of T2D," the authors write.
One author disclosed ties to Abbott, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-31 06:00
Read more
- Cases of Tularemia, Highly Infectious Disease Spread by Rodents, Rabbits, and Bugs That Bite Them, Climb
- ADHD Diagnoses On The Rise Among Adults
- Tourette Syndrome Often Overlooked in Girls
- Health Officials Alarmed by Tuberculosis Outbreak in Kansas
- CPR Coach Training Boosts Coach Presence on Code Teams in Pediatric ICU
- Blood Test Accurately Detects Colon Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions